-+ 0.00%
-+ 0.00%
-+ 0.00%

TRINITY BIOTECH SECURES KEY REGULATORY APPROVAL FOR OFFSHORED AND OUTSOURCED MANUFACTURING OF ITS FLAGSHIP RAPID HIV TEST, ACCELERATING STRATEGIC & FINANCIAL PERFORMANCE TRANSFORMATION

Reuters·06/24/2025 12:00:38

Please log in to view news